RT Journal Article
SR Electronic
T1 Distributing Safer Smoking Pipes Increases Engagement with Harm Reduction Services in the United States: Findings from the National Survey of Syringe Services Programs
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.28.24309683
DO 10.1101/2024.06.28.24309683
A1 Chung, Esther O.
A1 Patel, Sheila V.
A1 Wenger, Lynn D.
A1 Humphrey, Jamie L.
A1 Bluthenthal, Ricky N.
A1 Tookes, Hansel E.
A1 Des Jarlais, Don C.
A1 Glick, Sara N.
A1 LaKosky, Paul A.
A1 Prohaska, Stephanie
A1 Guzman, Laura
A1 Kral, Alex H.
A1 Lambdin, Barrot H.
A1 ,
YR 2024
UL http://medrxiv.org/content/early/2024/07/01/2024.06.28.24309683.abstract
AB Background In response to the recent and growing shift from injecting opioids to smoking fentanyl, an increasing number of syringe services programs (SSPs) in the USA are distributing safer smoking supplies. A recent federal ban prevents SSPs from using federal funding to procure safer smoking supplies. There is a lack of research on safer smoking supply distribution and harm reduction outcomes. Therefore, we assessed the relationship between distribution of safer smoking supplies by SSPs and levels of participant engagement and naloxone distribution.Methods We used data from the 2023 National Survey of Syringe Services Programs (NSSSP) (N=429), which measured services delivered in 2022. SSPs reported whether they distributed safer smoking pipes (yes/no). We examined the relationship between safer smoking pipe distribution and two outcomes: the number of participant encounters and naloxone doses distributed.Results There were 187 SSPs (43.6%) that distributed pipes for smoking to participants. Compared to SSPs that did not distribute pipes, those that distributed pipes reported more participant encounters (aRR=1.49, 95% CI: 1.09-2.02) and naloxone dose distribution (aRR=1.21, 95% CI: 0.89-1.65), though this latter finding was not statistically significant.Conclusions Findings showed SSPs distributing safer smoking pipes had more participant engagement and naloxone distribution. To maximize their full individual and population-level health benefits, SSPs should be supported technically, legally, and financially to implement safer smoking supply distribution for their participants.HighlightsIn 2022, 44% of syringe services programs (SSPs) distributed safer smoking pipes.More community-based organizations distributed pipes than public health or health care programs.Distribution of safer smoking pipes was associated with more participant encounters.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Centers for Disease Control (Award #: 5 NU52PS910232-01-00). The funders had no role in the data analysis, decision to publish, or manuscript preparation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethic committee/IRB of Research Triangle Institute (RTI) International determined this research was not human subjects research and waived ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes